Vanillin accelerates chronic wound healing in animal studies

Flinders University research shows vanilla-derived compound closes wounds faster in lab animals

Flinders University published findings in the *International Journal of Pharmaceutics* demonstrating vanillin—derived from cured vanilla pods—accelerates healing of chronic wounds in mice and rats. The compound achieves 94-96% wound closure within 2-3 weeks for conditions including diabetic foot ulcers and non-healing surgical wounds. Vanillin works by reducing inflammation, stimulating blood vessel formation, and binding reversibly with chitosan in hydrogel dressings. However, the results come from animal studies only; human clinical trials remain pending. Effectiveness also depends on combining vanillin with supportive materials like chitosan. This research offers a potential pathway for cheaper wound care solutions using existing, low-cost synthetic vanillin, but current evidence does not confirm human cost savings or clinical viability. The next step requires human trials to validate safety and efficacy before medical application.

Source: New Atlas